Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alcon AG (ALC) vs Celsius Holdings, Inc. (CELH) Price & Performance

Celsius Holdings, Inc.Trade

Price performance (Past 24H)

Key statistics

Alcon AG vs Celsius Holdings, Inc. — how do they compare? Alcon AG trades at $72.57 (market cap $36.44B), while Celsius Holdings, Inc. trades at $28.08 (market cap $7.11B). The key difference: Alcon AG is far larger — about 5.1× Celsius Holdings, Inc.'s market cap, and Alcon AG pays a 0.48% dividend while Celsius Holdings, Inc. pays none. Which is the better fit depends on your goals.

ALCCELH
Market Cap
$36.44B$7.11B
Sector
HealthConsumer Staples
52-Week High
$90.12$64.86
52-Week Low
$62.02$23.77
Enterprise Value
$40.28B$8.90B
Dividend Yield
0.48%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alcon AG

No Aura AI signal available yet.

Celsius Holdings, Inc.

CELH trades at $27.21, down 2.02% on the day, with technical indicators signaling a bearish trend. The company reported Q2 2026 earnings of $0.36 per share, missing estimates of $0.4139, while revenue grew 11% year-over-year. Recent news highlights leadership changes and an ongoing shareholder investigation. The stock faces pressure from slowing core-brand growth but benefits from strong analyst support and a partnership with PepsiCo.

Outlook: High growth potential via international expansion and PepsiCo distribution, but execution risks and margin pressures persist. Risks include competitive threats and delayed growth projections. Analyst consensus is strongly bullish with a $44.08 price target, suggesting significant upside if operational challenges are overcome.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Alcon AG

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.

Read more on ALC

About Celsius Holdings, Inc.

Celsius Holdings Inc engages in the development, marketing, sale, and distribution of functional calorie-burning beverages. It offers flavors including cola, orange, wild berry and lemon iced tea and non-carbonated flavors such as Raspberry Acai Green Tea and Peach Mango Green Tea under the Celsius brand name. The company distributes its products through direct-store-delivery distributors, as well as directly to retailers across various retail segments, including supermarkets, convenience stores, drug stores, nutritional stores, mass merchants, health clubs, spas, gyms, military, and e-commerce websites.

Read more on CELH